Advertisement

Journal of Thermal Analysis and Calorimetry

, Volume 78, Issue 1, pp 83–89 | Cite as

Evaluation of an index based on van't Hoff equation to predict PEG-drug eutectic composition

  • L. M. Oberoi
  • K. S. Alexander
  • A.T. Riga
Article

Abstract

Five poorly soluble drugs namely hydrochlorothiazide, menadione, propylthiouracil, quinine sulfate and sulfamerazine were used to evaluate the ability of an index (I c) based on the van't Hoff equation to predict the eutectic composition at a higher heating rate than previously published. The term I c is a dimensionless index which has been defined in the literature and is used to predict eutectic composition. This current work uses this study to determine if the correlation holds true at the higher heating rate of 10°C min-1. The maximum deviation was observed for quinine sulfate, for which the predicted eutectic composition was 10% lower than what was observed with the DSC. It can be concluded that the Index developed here has a good correlation with the experimentally determined eutectic composition.

phase diagrams PEG eutectic van't Hoff equation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    K. Sekiguchi and N. Obi, Chem. Pharm. Bull., 9 (1961) 866.Google Scholar
  2. 2.
    M. J. Alonso, P. Maincent, T. Gracia-Arias and J. L. Vila-Jato, Int. J. Pharm., 42 (1988) 27.CrossRefGoogle Scholar
  3. 3.
    S. Lerdkanchanaporn, D. Dollimore and S. J. Evans, Thermochim. Acta, 1 (2001) 367.Google Scholar
  4. 4.
    Z. Naima, T. Siro, G. Juan-Manuel, C. Chantal, C. René and D. Jerome, European J. Pharm. Sci., 12 (2001) 395.CrossRefGoogle Scholar
  5. 5.
    W. L. Chiou and S. Riegelman, J. Pharm. Sci., 60 (1971) 1281.Google Scholar
  6. 6.
    J. M. Ginés, M. J. Arias, J. R. Moyano, Cs. Novak, G. Pokol and P. J. Sánchez-Soto, J. Thermal Anal., 47 (1996) 1743.CrossRefGoogle Scholar
  7. 7.
    P. Mura, A. Manderioli, G. Bramanti and L. Ceccarelli, Drug Dev. Ind. Pharm., 22 (1996) 909.Google Scholar
  8. 8.
    P. W. Stott, A. C. Williams and B. W. Barry, J. Controlled Release, 50 (1998) 297.CrossRefGoogle Scholar
  9. 9.
    F. Taneri, T. Güneri, Z. Aigner, O. Berkesi and M. Kata, J. Therm. Anal. Cal., 76 (2004) 471.CrossRefGoogle Scholar
  10. 10.
    A. Agostiano, L. Catucci, M. Castagnolo, D. Colangelo, P. Cosma, P. Fini and M. Della Monica, J. Therm. Anal. Cal., 70 (2002) 115.CrossRefGoogle Scholar
  11. 11.
    D. Law, W. Wang, E. A. Schmitt and M. A. Long, Pharm. Res., 19 (2002) 315.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publisher/Akadémiai Kiadó 2004

Authors and Affiliations

  • L. M. Oberoi
    • 1
  • K. S. Alexander
    • 2
  • A.T. Riga
    • 3
  1. 1.College of Pharmacy, Industrial Pharmacy DivisionThe University of Toledo ToledoOhio 43606 E-mail
  2. 2.College of Pharmacy, Industrial Pharmacy DivisionThe University of Toledo ToledoOhio 43606
  3. 3.Department of Clinical ChemistryCleveland State University ClevelandOhio-44115

Personalised recommendations